Solventum Corporation (SOLV) All Metrics
SOLV Valuation Metrics
SOLV Stock Price Metrics
SOLV Dividend Metrics
SOLV Growth Rate Metrics
SOLV Discounted Cash Flow Metrics
| Fair Value Price | $141.97 |
| Margin of Safety | 79.21% |
SOLV Revenue Metrics
SOLV PE Ratio Metrics
| PE Ratio | 9.70 |
| PE Ratio Avg TTM | 18.87 |
| PE Ratio Avg 3Y | 17.07 |
| Current VS TTM Avg | -48.61% |
| Current VS 3Y Avg | -43.18% |
| Current VS 5Y Avg | -43.18% |
SOLV PS Ratio Metrics
| PS Ratio | 1.68 |
| PS Ratio Avg TTM | 1.56 |
| PS Ratio Avg 3Y | 1.48 |
| Current VS TTM Avg | +7.99% |
| Current VS 3Y Avg | +13.69% |
| Current VS 5Y Avg | +13.69% |
SOLV PB Ratio Metrics
| PB Ratio | 2.80 |
| PB Ratio Avg TTM | 3.05 |
| PB Ratio Avg 3Y | 3.38 |
| Current VS TTM Avg | -8.28% |
| Current VS 3Y Avg | -17.09% |
| Current VS 5Y Avg | -17.09% |
SOLV Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 269.91 |
| PFCF Ratio Avg TTM | 116.92 |
| PFCF Ratio Avg 3Y | 65.01 |
| Current VS TTM Avg | +130.85% |
| Current VS 3Y Avg | +315.20% |
| Current VS 5Y Avg | +315.20% |
SOLV Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 1.00 |
| Debt/Equity Ratio Avg TTM | 1.85 |
| Debt/Equity Ratio Avg 3Y | 1.10 |
| Current VS TTM Avg | -46.09% |
| Current VS 3Y Avg | -9.50% |
| Current VS 5Y Avg | +35.75% |
SOLV PEG Ratio Metrics
| PEG Ratio | 0.04 |
| PEG Ratio Avg TTM | 0.04 |
| PEG Ratio Avg 3Y | 0.04 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
SOLV FCF Yield
| FCF Yield | 0.37% |
| FCF Yield Avg TTM | 2.46% |
| FCF Yield Avg 3Y | 7.43% |
| Current VS TTM Avg | -84.96% |
| Current VS 3Y Avg | -95.02% |
| Current VS 5Y Avg | -95.02% |
SOLV Earnings Yield
| Earnings Yield | 10.31% |
| Earnings Yield Avg TTM | 8.09% |
| Earnings Yield Avg 3Y | 8.15% |
| Current VS TTM Avg | +27.38% |
| Current VS 3Y Avg | +26.44% |
| Current VS 5Y Avg | +26.44% |
SOLV EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 8.73 |
| Ev/Ebit Ratio Avg TTM | 20.88 |
| Ev/Ebit Ratio Avg 3Y | 17.38 |
| Current VS TTM Avg | -58.20% |
| Current VS 3Y Avg | -49.76% |
| Current VS 5Y Avg | -49.76% |
SOLV EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 6.69 |
| Ev/Ebitda Ratio Avg TTM | 10.17 |
| Ev/Ebitda Ratio Avg 3Y | 10.29 |
| Current VS TTM Avg | -34.22% |
| Current VS 3Y Avg | -35.00% |
| Current VS 5Y Avg | -35.00% |
SOLV EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.31 |
| Ev/Assets Ratio Avg TTM | 1.27 |
| Ev/Assets Ratio Avg 3Y | 1.28 |
| Current VS TTM Avg | +3.25% |
| Current VS 3Y Avg | +2.01% |
| Current VS 5Y Avg | +2.01% |
SOLV EV/Sales Ratio Metrics
| Ev/Sales Ratio | 2.23 |
| Ev/Sales Ratio Avg TTM | 2.19 |
| Ev/Sales Ratio Avg 3Y | 2.26 |
| Current VS TTM Avg | +1.81% |
| Current VS 3Y Avg | -1.25% |
| Current VS 5Y Avg | -1.25% |
SOLV Current Ratio Metrics
| Current Ratio | 1.23 |
| Current Ratio Avg TTM | 1.21 |
| Current Ratio Avg 3Y | 1.40 |
| Current VS TTM Avg | +1.23% |
| Current VS 3Y Avg | -11.99% |
| Current VS 5Y Avg | -13.99% |
SOLV Quick Ratio Metrics
| Quick Ratio | 0.89 |
| Quick Ratio Avg TTM | 0.86 |
| Quick Ratio Avg 3Y | 0.93 |
| Current VS TTM Avg | +2.89% |
| Current VS 3Y Avg | -4.56% |
| Current VS 5Y Avg | -5.52% |
SOLV ROIC Metrics
| ROIC | 17.76% |
| ROIC Avg 3Y | 11.68% |
| ROIC Avg 5Y | 9.71% |
| Current VS 3Y Avg | +52.02% |
| Current VS 5Y Avg | +82.97% |
| Current VS 10Y Avg | +82.97% |
SOLV Return on Assets Metrics
| ROA | 10.89 |
| ROA Avg TTM | 7.10 |
| ROA Avg 3Y | 8.43 |
| Current VS TTM Avg | +53.38% |
| Current VS 3Y Avg | +29.14% |
| Current VS 5Y Avg | +48.16% |
SOLV Return on Equity Metrics
| ROE | 30.82 |
| ROE Avg TTM | 23.51 |
| ROE Avg 3Y | 17.50 |
| Current VS TTM Avg | +31.12% |
| Current VS 3Y Avg | +76.14% |
| Current VS 5Y Avg | +125.24% |
SOLV Net Profit Margin Metrics
| Net Profit Margin | 18.69% |
| Net Profit Margin Avg TTM | 12.25% |
| Net Profit Margin Avg 3Y | 14.36% |
| Current VS TTM Avg | +52.63% |
| Current VS 3Y Avg | +30.18% |
| Current VS 5Y Avg | +23.33% |
Last Updated: Friday, June 12, 2026
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson